Ghost-Tree-Capital

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AXSM",
  "ASND",
  "EWTX",
  "INSM",
  "ABSI",
  "TGTX",
  "APLS",
  "RGNX",
  "ARVN",
  "ANNX",
  "OLMA",
  "CATX",
  "SVRA",
  "TSHA",
  "NUVB",
  "SMMT",
  "LRMR",
  "REPL",
  "PHAT",
  "SNDX",
  "NGNE",
  "AMLX",
  "JANX",
  "SYRE",
  "TARS",
  null,
  "KRRO",
  "PRQR",
  "TNYA",
  "ATYR",
  "RZLT",
  "RYTM",
  "MLTX",
  "SLNO",
  "DYN",
  "SRPT",
  "ROIV",
  null,
  null,
  "CRVS",
  "NVO",
  "VKTX",
  "VRDN",
  "IMVT",
  "PCVX",
  null,
  "BPMC",
  "BBIO",
  "CAPR",
  "CGON",
  "CRBP",
  "CRNX"
]

Filing Details

13F-HR • 2024-09-30

SEC FilingSEC DataHachi Filing

Report Date: 2024-09-30
Filing Date: 2024-11-14
Total Holdings: 52
Total Value: 322268332
Accession Number: 0001420506-24-002434
Form Type: 13F-HR
CIK: ghost-tree-capital
Manager Name: Ghost-Tree-Capital

Data Enrichment

92% identified

48 identified4 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

52 positions • $322.3M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 3

Sort by:

MoonLake Immunotherapeutics

MLTX|61559X104

Shares:128.4K

Value:$6.5M

% of Portfolio:2.0% ($6.5M/$322.3M)

Olema Pharmaceuticals, Inc.

OLMA|68062P106

Shares:535.0K

Value:$6.4M

% of Portfolio:2.0% ($6.4M/$322.3M)

Immunovant, Inc.

IMVT|45258J102

Shares:215.0K

Value:$6.1M

% of Portfolio:1.9% ($6.1M/$322.3M)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:195.0K

Value:$5.2M

% of Portfolio:1.6% ($5.2M/$322.3M)

Replimune Group, Inc.

REPL|76029N106

Shares:450.0K

Value:$4.9M

% of Portfolio:1.5% ($4.9M/$322.3M)

Corbus Pharmaceuticals Holdings, Inc.

CRBP|21833P301

Shares:220.0K

Value:$4.5M

% of Portfolio:1.4% ($4.5M/$322.3M)

BridgeBio Pharma, Inc.

BBIO|10806X102

Shares:175.0K

Value:$4.5M

% of Portfolio:1.4% ($4.5M/$322.3M)

Taysha Gene Therapies, Inc.

TSHA|877619106

Shares:2.1M

Value:$4.3M

% of Portfolio:1.3% ($4.3M/$322.3M)

RHYTHM PHARMACEUTICALS, INC.

RYTM|76243J105

Shares:78.8K

Value:$4.1M

% of Portfolio:1.3% ($4.1M/$322.3M)

Annexon, Inc.

ANNX|03589W102

Shares:650.0K

Value:$3.8M

% of Portfolio:1.2% ($3.8M/$322.3M)

Korro Bio, Inc.

KRRO|500946108

Shares:110.0K

Value:$3.7M

% of Portfolio:1.1% ($3.7M/$322.3M)

INSMED Inc

INSM|457669307

Shares:50.0K

Value:$3.6M

% of Portfolio:1.1% ($3.6M/$322.3M)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:100.0K

Value:$3.6M

% of Portfolio:1.1% ($3.6M/$322.3M)

ARVINAS, INC.

ARVN|04335A105

Shares:145.0K

Value:$3.6M

% of Portfolio:1.1% ($3.6M/$322.3M)

G4444H101

Shares:300.0K

Value:$3.1M

% of Portfolio:1.0% ($3.1M/$322.3M)

Nuvation Bio Inc.

NUVB|67080N101

Shares:1.4M

Value:$3.1M

% of Portfolio:1.0% ($3.1M/$322.3M)

Savara Inc

SVRA|805111101

Shares:725.0K

Value:$3.1M

% of Portfolio:1.0% ($3.1M/$322.3M)

Tenaya Therapeutics, Inc.

TNYA|87990A106

Shares:1.5M

Value:$2.9M

% of Portfolio:0.9% ($2.9M/$322.3M)

REGENXBIO Inc.

RGNX|75901B107

Shares:265.0K

Value:$2.8M

% of Portfolio:0.9% ($2.8M/$322.3M)

Corvus Pharmaceuticals, Inc.

CRVS|221015100

Shares:500.0K

Value:$2.6M

% of Portfolio:0.8% ($2.6M/$322.3M)

Instrument	Shares		Other Manager	Value	% of Portfolio
MoonLake Immunotherapeutics(MLTXcusip61559X104)	128.4K	QoQ -57.19% (-171.6K) YoY-	All Managers (Combined)	$6.5M	2.0% ($6.5M/$322.3M)	QoQ -50.91% (-$6.7M) YoY-
Olema Pharmaceuticals, Inc.(OLMAcusip68062P106)	535.0K	QoQ -2.72% (-15.0K) YoY-	All Managers (Combined)	$6.4M	2.0% ($6.4M/$322.3M)	QoQ +7.34% (-$436.9K) YoY-
Immunovant, Inc.(IMVTcusip45258J102)	215.0K	QoQ -17.30% (-45.0K) YoY-	All Managers (Combined)	$6.1M	1.9% ($6.1M/$322.3M)	QoQ -10.69% (-$734.4K) YoY-
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	195.0K	QoQ NEW(+195.0K) YoY-	All Managers (Combined)	$5.2M	1.6% ($5.2M/$322.3M)	QoQ NEW(+$5.2M) YoY-
Replimune Group, Inc.(REPLcusip76029N106)	450.0K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$4.9M	1.5% ($4.9M/$322.3M)	QoQ +21.77% (+$882.0K) YoY-
Corbus Pharmaceuticals Holdings, Inc.(CRBPcusip21833P301)	220.0K	QoQ +25.71% (-45.0K) YoY-	All Managers (Combined)	$4.5M	1.4% ($4.5M/$322.3M)	QoQ -42.68% (-$3.4M) YoY-
BridgeBio Pharma, Inc.(BBIOcusip10806X102)	175.0K	QoQ +25.00% (+35.0K) YoY-	All Managers (Combined)	$4.5M	1.4% ($4.5M/$322.3M)	QoQ +25.64% (+$909.3K) YoY-
Taysha Gene Therapies, Inc.(TSHAcusip877619106)	2.1M	QoQ +72.00% (+900.0K) YoY-	All Managers (Combined)	$4.3M	1.3% ($4.3M/$322.3M)	QoQ +54.33% (+$1.5M) YoY-
RHYTHM PHARMACEUTICALS, INC.(RYTMcusip76243J105)	78.8K	QoQ -32.83% (-38.5K) YoY-	All Managers (Combined)	$4.1M	1.3% ($4.1M/$322.3M)	QoQ -14.30% (-$689.4K) YoY-
Annexon, Inc.(ANNXcusip03589W102)	650.0K	QoQ +203.03% (+435.5K) YoY-	All Managers (Combined)	$3.8M	1.2% ($3.8M/$322.3M)	QoQ +266.11% (+$2.8M) YoY-
Korro Bio, Inc.(KRROcusip500946108)	110.0K	QoQ +10.00% (+10.0K) YoY-	All Managers (Combined)	$3.7M	1.1% ($3.7M/$322.3M)	QoQ +8.53% (+$289.2K) YoY-
INSMED Inc(INSMcusip457669307)	50.0K	QoQ -75.00% (-150.0K) YoY-	All Managers (Combined)	$3.6M	1.1% ($3.6M/$322.3M)	QoQ -72.76% (-$9.8M) YoY-
Dyne Therapeutics, Inc.(DYNcusip26818M108)	100.0K	QoQ NEW(+100.0K) YoY-	All Managers (Combined)	$3.6M	1.1% ($3.6M/$322.3M)	QoQ NEW(+$3.6M) YoY-
ARVINAS, INC.(ARVNcusip04335A105)	145.0K	QoQ +93.33% (+70.0K) YoY-	All Managers (Combined)	$3.6M	1.1% ($3.6M/$322.3M)	QoQ +78.88% (+$1.6M) YoY-
(cusipG4444H101)✕	300.0K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$3.1M	1.0% ($3.1M/$322.3M)	QoQ +2.25% (+$69.0K) YoY-
Nuvation Bio Inc.(NUVBcusip67080N101)	1.4M	QoQ +17.39% (-200.0K) YoY-	All Managers (Combined)	$3.1M	1.0% ($3.1M/$322.3M)	QoQ -7.93% (-$266.5K) YoY-
Savara Inc(SVRAcusip805111101)	725.0K	QoQ -31.00% (-325.9K) YoY-	All Managers (Combined)	$3.1M	1.0% ($3.1M/$322.3M)	QoQ -27.41% (-$1.2M) YoY-
Tenaya Therapeutics, Inc.(TNYAcusip87990A106)	1.5M	QoQ +11.11% (-150.0K) YoY-	All Managers (Combined)	$2.9M	0.9% ($2.9M/$322.3M)	QoQ -30.82% (-$1.3M) YoY-
REGENXBIO Inc.(RGNXcusip75901B107)	265.0K	QoQ +55.88% (+95.0K) YoY-	All Managers (Combined)	$2.8M	0.9% ($2.8M/$322.3M)	QoQ +39.76% (+$790.9K) YoY-
Corvus Pharmaceuticals, Inc.(CRVScusip221015100)	500.0K	QoQ NEW(+500.0K) YoY-	All Managers (Combined)	$2.6M	0.8% ($2.6M/$322.3M)	QoQ NEW(+$2.6M) YoY-